Clinical Trial

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Name: Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia — clinical trial record (NCT07284472)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SERENADA

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

Protocol Amendment History 1 change

notable Trial sites expanded: 14 -> 49 locations 2026-06-06

Trial Details

NCT Number	NCT07284472
Lead Sponsor	Exciva GmbH
Conditions	Agitation Associated With Alzheimer's Disease Dementia
Enrollment	300 participants
Start Date	2026-02-02
Primary Completion	2029-01 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2026-08-14